251 related articles for article (PubMed ID: 17598435)
41. CYP2D6 polymorphism in relation to tramadol metabolism: a study of faroese patients.
Halling J; Weihe P; Brosen K
Ther Drug Monit; 2008 Jun; 30(3):271-5. PubMed ID: 18520597
[TBL] [Abstract][Full Text] [Related]
42. [Distribution of acetylator phenotypes in the normal Moscow city population and in chronic alcoholism].
Lil'in ET; Korsunskaia MP; Meksin VA; Drozdov ES; Nazarov VV
Genetika; 1984 Sep; 20(9):1557-9. PubMed ID: 6542045
[TBL] [Abstract][Full Text] [Related]
43. [A susceptible factor to acquire parkinsonism: sparteine oxidation polymorphism].
Chiba K
Rinsho Shinkeigaku; 1989 Dec; 29(12):1507-9. PubMed ID: 2630146
[TBL] [Abstract][Full Text] [Related]
44. Relationship between metabolic phenotype of N-acetylation and bladder cancer.
Cui X; Guo R; Xu Z; Wang B; Li C
Chin Med J (Engl); 2000 Apr; 113(4):303-5. PubMed ID: 11775223
[TBL] [Abstract][Full Text] [Related]
45. Genetically determined sparteine oxidation polymorphism in a Polish population.
Orzechowska-Juzwenko K; Pawlik J; Niewiński P; Milejski P; Dembowski J; Turek J; Goździk A; Swiebodzki L; Hora Z
Eur J Clin Pharmacol; 1994; 46(5):481-3. PubMed ID: 7957549
[TBL] [Abstract][Full Text] [Related]
46. [The polymorphism of pachycarpine oxidation].
Piotrovskiĭ VK; Belolipetskaia VG; Rumiantsev DO; Metelitsa VI
Eksp Klin Farmakol; 1992; 55(4):56-8. PubMed ID: 1458193
[TBL] [Abstract][Full Text] [Related]
47. Genetically determined N-acetylation and oxidation capacities in Japanese patients with non-occupational urinary bladder cancer.
Horai Y; Fujita K; Ishizaki T
Eur J Clin Pharmacol; 1989; 37(6):581-7. PubMed ID: 2612554
[TBL] [Abstract][Full Text] [Related]
48. Presenilin-1 gene intronic polymorphism and late-onset Alzheimer's disease.
Dursun E; Gezen-Ak D; Eker E; Ertan T; Engin F; Hanagasi H; Gürvit H; Emre M; Yilmazer S
J Geriatr Psychiatry Neurol; 2008 Dec; 21(4):268-73. PubMed ID: 19017784
[TBL] [Abstract][Full Text] [Related]
49. Pharmacogenomics in Alzheimer's disease.
Cacabelos R
Methods Mol Biol; 2008; 448():213-357. PubMed ID: 18370236
[TBL] [Abstract][Full Text] [Related]
50. [Acetylation phenotype in patients with lung cancer].
Cofta S; Lowicki Z; Młynarczyk W
Pneumonol Alergol Pol; 1995; 63(7-8):407-9. PubMed ID: 8520558
[TBL] [Abstract][Full Text] [Related]
51. No association of spastic paraparesis genes in PSEN1 Alzheimer's disease with spastic paraparesis.
Karlstrom H; Kwok JB; Gregory GC; Hallupp M; Brooks WS; Schofield PR
Neuroreport; 2007 Aug; 18(12):1267-9. PubMed ID: 17632280
[TBL] [Abstract][Full Text] [Related]
52. N-acetylation phenotyping with sulphadimidine in a Turkish population.
Bozkurt A; Basci NE; Kalan S; Tuncer M; Kayaalp SO
Eur J Clin Pharmacol; 1990; 38(1):53-6. PubMed ID: 2328748
[TBL] [Abstract][Full Text] [Related]
53. Acetylator polymorphism in human colorectal carcinoma.
Ladero JM; González JF; Benítez J; Vargas E; Fernández MJ; Baki W; Diaz-Rubio M
Cancer Res; 1991 Apr; 51(8):2098-100. PubMed ID: 2009528
[TBL] [Abstract][Full Text] [Related]
54. Acetylator phenotyping in patients with malignant lymphomas, using caffeine as the metabolic probe.
William BM; Abdel-tawab AM; Hassan EA; Mohamed OF
Pol J Pharmacol; 2004; 56(4):445-9. PubMed ID: 15520499
[TBL] [Abstract][Full Text] [Related]
55. 14-3-3 zeta and tau genes interactively decrease Alzheimer's disease risk.
Mateo I; Sánchez-Juan P; Rodríguez-Rodríguez E; Infante J; Fernández-Viadero C; Peña N; Berciano J; Combarros O
Dement Geriatr Cogn Disord; 2008; 25(4):317-20. PubMed ID: 18319590
[TBL] [Abstract][Full Text] [Related]
56. Effect of exercise on plasma levels and urinary excretion of sulphadimidine and procainamide.
Ylitalo P; Hinkka H
Int J Clin Pharmacol Ther Toxicol; 1985 Oct; 23(10):548-53. PubMed ID: 4066079
[TBL] [Abstract][Full Text] [Related]
57. [Impact of music therapy on anxiety and depression for patients with Alzheimer's disease and on the burden felt by the main caregiver (feasibility study)].
Guetin S; Portet F; Picot MC; Defez C; Pose C; Blayac JP; Touchon J
Encephale; 2009 Feb; 35(1):57-65. PubMed ID: 19250995
[TBL] [Abstract][Full Text] [Related]
58. Acetylator phenotype in Iraqi patients with atopic dermatitis.
Najim RA; Al-Waiz MM; Al-Razzuqi RA
Dermatol Online J; 2006 Dec; 12(7):1. PubMed ID: 17459287
[TBL] [Abstract][Full Text] [Related]
59. Hepatic acetylator phenotype in diabetes mellitus.
Ladero JM; Arrojo A; de Salamanca RE; Gomez M; Cano F; Alfonso M
Ann Clin Res; 1982 Aug; 14(4):187-9. PubMed ID: 7168549
[TBL] [Abstract][Full Text] [Related]
60. Butyrylcholinesterase, ApoE and Alzheimer's disease in a population from the Canary Islands (Spain).
Déniz-Naranjo MC; Muñoz-Fernández C; Alemany-Rodríguez MJ; del Carmen Pérez-Vieitez M; Aladro-Benito Y; Irurita-Latasa J; Sánchez-García F
Neurosci Lett; 2007 Oct; 427(1):34-8. PubMed ID: 17923322
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
